Literature DB >> 17891746

Glomerular and tubular induction of the transcription factor c-Jun in human renal disease.

M H De Borst1, J Prakash, W B W H Melenhorst, M C van den Heuvel, R J Kok, G Navis, H van Goor.   

Abstract

The transcription factor c-Jun regulates the expression of genes involved in proliferation and inflammation in many cell types but its role in human renal disease is largely unclear. In the current study we investigated whether c-Jun activation is associated with human renal disease and if c-Jun activation regulates pro-inflammatory and pro-fibrotic genes in renal cells. Activation of c-Jun was quantified by scoring renal expression of phosphorylated c-Jun (pc-Jun) in control human renal tissue and in biopsies from patients with various renal diseases (diabetic nephropathy, focal glomerulosclerosis, hypertension, IgA nephropathy, membranous glomerulopathy, minimal change disease, membranoproliferative glomerulonephritis, systemic lupus erythematosus, acute rejection, and Wegener's granulomatosis); this was correlated with parameters of renal damage. Furthermore, we studied the functional role of c-Jun activation in human tubular epithelial cells (HK-2) stimulated with TGF-beta. Activated c-Jun was present in nuclei of glomerular and tubular cells in all human renal diseases, but only sporadically in controls. Across the diseases, the extent of pc-Jun expression correlated with the degree of focal glomerulosclerosis, interstitial fibrosis, cell proliferation, kidney injury molecule-1 (Kim-1) expression, macrophage accumulation, and impairment of renal function. In HK-2 cells, TGF-beta induced c-Jun activation after 1 h (+40%, p < 0.001) and 24 h (+160%, p < 0.001). The specific c-Jun N-terminal kinase (JNK) inhibitor SP600125 abolished c-Jun phosphorylation at all time points and blunted TGF-beta- or BSA-induced procollagen-1alpha 1 and MCP-1 gene expression in HK-2 cells. We conclude that in human renal disease, the transcription factor c-Jun is activated in glomerular and tubular cells. Activation of c-Jun may be involved in the regulation of inflammation and/or fibrosis in human renal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891746     DOI: 10.1002/path.2228

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  36 in total

Review 1.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

2.  Focal adhesion kinase signaling mediates acute renal injury induced by ischemia/reperfusion.

Authors:  Yu Qin; Maaike C Alderliesten; Geurt Stokman; Petra Pennekamp; Joseph V Bonventre; Emile de Heer; Takaharu Ichimura; Marjo de Graauw; Leo S Price; Bob van de Water
Journal:  Am J Pathol       Date:  2011-10-05       Impact factor: 4.307

3.  Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains.

Authors:  Yohan Kim; Guanghao Liu; Chad J Leugers; Joseph D Mueller; Meghan B Francis; Marco M Hefti; Julie A Schneider; Gloria Lee
Journal:  J Cell Sci       Date:  2019-07-15       Impact factor: 5.285

4.  The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.

Authors:  Lei Zhang; Jian-Bing Hao; Lian-Sheng Ren; Jiu-Li Ding; Li-Rong Hao
Journal:  Lab Invest       Date:  2014-05-26       Impact factor: 5.662

5.  APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.

Authors:  Opeyemi A Olabisi; Jia-Yue Zhang; Lynn VerPlank; Nathan Zahler; Salvatore DiBartolo; John F Heneghan; Johannes S Schlöndorff; Jung Hee Suh; Paul Yan; Seth L Alper; David J Friedman; Martin R Pollak
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-23       Impact factor: 11.205

6.  Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor.

Authors:  Nancy-Ellen Haynes; Nathan R Scott; Li C Chen; Cheryl A Janson; Jia Kui Li; Christine M Lukacs; Aruna Railkar; Effie Tozzo; Toni Whittard; Nicholas F Brown; Adrian Wai-Hing Cheung
Journal:  ACS Med Chem Lett       Date:  2012-08-08       Impact factor: 4.345

7.  ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Authors:  John T Liles; Britton K Corkey; Gregory T Notte; Grant R Budas; Eric B Lansdon; Ford Hinojosa-Kirschenbaum; Shawn S Badal; Michael Lee; Brian E Schultz; Sarah Wise; Swetha Pendem; Michael Graupe; Laurie Castonguay; Keith A Koch; Melanie H Wong; Giuseppe A Papalia; Dorothy M French; Theodore Sullivan; Erik G Huntzicker; Frank Y Ma; David J Nikolic-Paterson; Tareq Altuhaifi; Haichun Yang; Agnes B Fogo; David G Breckenridge
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

8.  SP600125, an inhibitor of c-Jun NH2-terminal kinase, blocks expression of angiotensin II-induced monocyte chemoattractant protein-1 in human mesangial cells.

Authors:  Gui-Xia Ding; Ai-Hua Zhang; Song-Ming Huang; Xiao-Qin Pan; Rong-Hua Chen
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

Review 9.  Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney.

Authors:  Rajeev Rohatgi; Daniel Flores
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

Review 10.  Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.

Authors:  Siddesh Jaiman; Arun Kumar Sharma; Kulwant Singh; Deepa Khanna
Journal:  Eur J Clin Pharmacol       Date:  2013-08-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.